Firms
Stead Impact Ventures
Stead Impact Ventures is a Stead family office founded by Jerre Stead in 2023. It invests in early-stage healthcare companies addressing neurodegenerative disorders, mental health and metabolic health, and supports founders with leadership, commercialization, marketing and strategic partnerships. Its published portfolio includes neuroscience diagnostics and therapeutics developers ALZpath, Amydis and Spinogenix, AI ergonomics company Inseer, patient monitoring developer Darroch Medical Solutions and MedWatch Technologies, which combines non-invasive glucose sensing with AI coaching. Venture investments operate alongside the Stead Foundation’s separate philanthropic grants. No externally raised fund closing or fund size was established from the available primary sources.
- Founded
- 2023
- Type
- Venture capital
Funds0
No funds on record yet.
Team
Operations and support
 Aidan ThompsonChief Commercial Officer |
 Dana LarsonChief Marketing Officer |
 Jacquee NickersonExecutive Assistant |
 Jay SteadBoard Member |
 Jerre SteadFounder and Board Chair |
 Joel SteadBoard Member |
 Sandy RosenbergSenior Advisor |
 Tiffani ShawChief Executive Officer · Board Member |
Co-investing
Merkava Holdings
Spinogenix$— · Unknown date
Investments
| $—Unknown date |  Inseer | Stead Impact Ventures |
| $15MUnknown date |  MedWatch Technologies | Stead Impact Ventures |
| $—Unknown date |  ALZpath | Stead Impact Ventures |
| $—Unknown date |  Amydis | Stead Impact Ventures |
| $—Unknown date | Spinogenix | Merkava Holdings, Stead Impact Ventures |